AU2002351176A1 - Peptides and use thereof in therapeutic agents against hiv infection - Google Patents

Peptides and use thereof in therapeutic agents against hiv infection

Info

Publication number
AU2002351176A1
AU2002351176A1 AU2002351176A AU2002351176A AU2002351176A1 AU 2002351176 A1 AU2002351176 A1 AU 2002351176A1 AU 2002351176 A AU2002351176 A AU 2002351176A AU 2002351176 A AU2002351176 A AU 2002351176A AU 2002351176 A1 AU2002351176 A1 AU 2002351176A1
Authority
AU
Australia
Prior art keywords
peptides
therapeutic agents
hiv infection
against hiv
agents against
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2002351176A
Other versions
AU2002351176A8 (en
Inventor
Pierre-Francois Serre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mymetics Corp
Original Assignee
Mymetics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR0115423A external-priority patent/FR2832715A1/en
Application filed by Mymetics Corp filed Critical Mymetics Corp
Publication of AU2002351176A1 publication Critical patent/AU2002351176A1/en
Publication of AU2002351176A8 publication Critical patent/AU2002351176A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
AU2002351176A 2001-11-29 2002-11-27 Peptides and use thereof in therapeutic agents against hiv infection Abandoned AU2002351176A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR0115423A FR2832715A1 (en) 2001-11-29 2001-11-29 New peptide containing 25 - 40 amino acids and a sequence useful as therapeutic agents in the treatment of HIV virus infections
FR0115423 2001-11-29
US34049201P 2001-12-18 2001-12-18
US60/340,492 2001-12-18
PCT/US2002/038152 WO2003048187A2 (en) 2001-11-29 2002-11-27 Peptides and use thereof in therapeutic agents against hiv infection

Publications (2)

Publication Number Publication Date
AU2002351176A1 true AU2002351176A1 (en) 2003-06-17
AU2002351176A8 AU2002351176A8 (en) 2003-06-17

Family

ID=26213281

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002351176A Abandoned AU2002351176A1 (en) 2001-11-29 2002-11-27 Peptides and use thereof in therapeutic agents against hiv infection

Country Status (2)

Country Link
AU (1) AU2002351176A1 (en)
WO (1) WO2003048187A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140335119A1 (en) * 2004-02-06 2014-11-13 Institut National De La Sante Et De La Recherche Medicale (Inserm) POLYPEPTIDE DERIVED FROM gp41, A VACCINE COMPOSITION COMPRISING SAID POLYPEPTIDE, AND USES FOR TREATING AN INFECTION BY AN HIV VIRUS IN AN INDIVIDUAL
WO2014002089A1 (en) * 2012-06-27 2014-01-03 Yeda Research And Development Co. Ltd. Peptides derived from hiv gp41 for treating t-cell mediated pathologies

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5444044A (en) * 1992-03-26 1995-08-22 New York Blood Center Synthetic polypeptides as inhibitors of HIV-1
EP0652895B1 (en) * 1992-07-20 1999-08-18 Duke University Compounds which inhibit hiv replication
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission

Also Published As

Publication number Publication date
WO2003048187A3 (en) 2004-04-29
AU2002351176A8 (en) 2003-06-17
WO2003048187A2 (en) 2003-06-12

Similar Documents

Publication Publication Date Title
AU2001293553A1 (en) Phosphatidylserine-carrying apoptosis-mimicking bodies and the use thereof in medical treatment
AU2002213357A1 (en) Variant igg3 rituxan r and therapeutic use thereof
AU2002234643A1 (en) Amphoteric liposomes and the use thereof
AU2002346504A1 (en) Therapeutic protein and treatments
AU2001233296A1 (en) Establishing and maintaining therapeutic hypothermia
AU1164601A (en) Therapeutic use and formulation
WO2003099841A9 (en) Peptides and the use thereof in darkening the skin
AU2002252976A1 (en) Hydrazones and their therapeutic use
SI1462455T1 (en) Ser-Ser-Ser-Arg peptide and medicinal uses thereof
EP1554306A4 (en) Conjugates comprised of polymer and hiv gp41-derived peptides and their use in therapy
AU2002234773A1 (en) Pharmaceutically effective ginsenosides and their use
AU2001292797A1 (en) Metal complexes for use in medical and therapeutic applications
AU2002354070A1 (en) Medical polymers and use thereof
AU2002222557A1 (en) Interferon therapeutic effect-potentiating agents
AU2001277696A1 (en) Novel physiologically active peptide and use thereof
AU2002351176A1 (en) Peptides and use thereof in therapeutic agents against hiv infection
AU2002230129A1 (en) Novel physiologically active peptide and use thereof
AUPR548601A0 (en) Pyrazolopyrazinecompound and pharmaceutical use thereof
AU7684000A (en) Interferon complex and medicinal use thereof
AU2001248750A1 (en) Novel physiologically active peptides and use thereof
AU2002324731A1 (en) New peptides and use thereof in therapeutic agents against feline fiv infection
AU2001272552A1 (en) Oxygen-enriched agent and the use thereof for therapeutic purposes
AU2002237251A1 (en) A pharmaceutical composition containing benzopyrano-oxopyrimidotetrahydrothiazine and its use in the treatment of hiv
AU2001254567A1 (en) Polypeptides for use as a vaccine and/or treatment for hiv infection
GB0017028D0 (en) Peptides and their therapeutic use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase